PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 26, 2026Biophysics Reviews0 citations

Analytical physics framework for competitive binding and transport in lateral flow assays: Application to fentanyl detection

View Full Paper
CLC. H. LinEWE. WangGLG. Luka

Key Points

  • To develop an analytical framework that enhances sensitivity in competitive lateral flow assays (cLFAs) for fentanyl detection.
  • Developed a physics-based model from first principles of transport and competitive binding.
  • Calculated closed-form expressions for limit of detection (LOD).
  • Applied the model using gold nanoparticle reporters for fentanyl detection.
  • Achieved ∼100-fold improvement in sensitivity over commercial fentanyl tests.
  • Identified key parameters influencing assay performance, such as antibody loading and nanoparticle concentration.

Abstract

Competitive lateral flow assays (cLFAs) have been widely used for decades, yet improvements in sensitivity remain largely empirical. A general physics-based model that predicts assay performance has been missing. We address this gap by developing an analytical framework derived from first principles of transport, competitive binding, and electrostatic interactions. The model provides closed-form expressions for the limit of detection (LOD), identifies the physical parameters that constrain sensitivity, and quantitatively links nanoparticle concentration, antibody loading, and electrostatic exclusion to the measured signal. To demonstrate generality and practical utility, we apply the model to fentanyl detection using gold nanoparticle reporters. Guided by the framework, we reduced antibody loading and minimized non-participating analyte effects, achieving a ∼100-fold improvement in sensitivity over commercial fentanyl tests (LOD ≈ 7 pg ml−1). This analytically tractable formulation offers a basis for predictive performance benchmarking and rational optimization of competitive LFAs and related point-of-care assays.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lin et al. (2026) studied this question.

synapsesocial.com/papers/69c4cda5fdc3bde44891a4a6https://doi.org/10.1063/5.0313042
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review2017 · 734 citations
  2. 2Comprehensive numerical prototyping of paper-based microfluidic devices using open-source tools2024 · 6 citations
  3. 3Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey2008 · 1,553 citations
  4. 4Lateral flow assays2016 · 1,168 citations
  5. 5Novel enzyme-linked aptamer-antibody sandwich assay and hybrid lateral flow strip for SARS-CoV-2 detection2024 · 24 citations